Search results
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News
MedPage Today· 1 day agoNews, features, and commentary about cancer-related issues
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
FOX 59 Indianapolis· 3 days agoUSA News Group – An alarming trend is happening around the world, where tens of millions of...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 2 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 days agoThe company is partnered with Merck on a cancer vaccine. The duo already has promising results in...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 2 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
BridgeBio taps VCs for $200M, fueling oncology spinout's push to surpass KRAS class
FierceBiotech· 2 days agoBridgeBio Pharma has spun its Rolodex to fund a subset of its sprawling list of opportunities. Busy...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 2 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 ...
Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY): Anti-Obesity Drug Market Could Reach Double...
The Wall Street Transcript· 5 days agoCiti Research Health Care Analyst Andrew Baum, M.D., maintains a “buy” recommendation on GLP-1...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 2 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...